ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SLTM Solta Medical, (MM)

2.93
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Solta Medical, (MM) NASDAQ:SLTM NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 2.93 0 01:00:00

INVESTOR ALERT Levi & Korsinsky, LLP Announces Investigation of SOLTA MEDICAL, INC. and Its Board of Directors In Relation to...

18/12/2013 9:39pm

PR Newswire (US)


Solta Medical, (MM) (NASDAQ:SLTM)
Historical Stock Chart


From Jun 2019 to Jun 2024

Click Here for more Solta Medical, (MM) Charts.

NEW YORK, Dec. 18, 2013 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Solta Medical, Inc. ("Solta Medical") (NasdaqGS: SLTM) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Valeant Pharmaceuticals International, Inc. (NYSE: VRX).

(Logo: http://photos.prnewswire.com/prnh/20120409/MM84375LOGO )

Click here to learn more about the action http://zlk.9nl.com/solta-medical-sltm/, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of transaction, Solta Medical shareholders will receive $2.92 in cash for each share of Solta Medical stock they own. The transaction has a total approximate value of $250 million. The investigation concerns whether the Solta Medical Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Valeant Pharmaceuticals International, Inc. is underpaying for Solta Medical shares. In particular, at least one analyst set a price target for Solta Medical stock at $4.00 per share.

If you own Solta Medical common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/ solta-medical-sltm/.  

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's 26 attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (866) 367-6510
www.zlk.com 

SOURCE Levi & Korsinsky, LLP

Copyright 2013 PR Newswire

1 Year Solta Medical, (MM) Chart

1 Year Solta Medical, (MM) Chart

1 Month Solta Medical, (MM) Chart

1 Month Solta Medical, (MM) Chart